| 發(fā)布日期: 2011-03-30 | 小 | 中 | 大 | 【關(guān)閉窗口】 |
|
醫(yī)藥板塊盤中明顯上揚(yáng),截至10:40,逾7成個(gè)股飄紅。西南藥業(yè)(13.48,-0.38,-2.74%)漲8.15%,迪康藥業(yè)(18.56,0.20,1.09%)漲7.04%,華神集團(tuán)(19.92,-0.68,-3.30%)漲5.74%,ST中源(15.74,0.75,5.00%)漲停,桐君閣(12.76,-0.08,-0.62%)漲4.03%;此外,中國(guó)醫(yī)藥(20.12,0.12,0.60%)、錢江生化(11.70,-0.07,-0.59%)、南京醫(yī)藥(12.68,0.13,1.04%)等漲幅均逾2%。 國(guó)金證券(15.44,-0.51,-3.20%)近日發(fā)表了醫(yī)藥行業(yè)研究報(bào)告,由于行業(yè)降價(jià)政策陸續(xù)出臺(tái)并趨緩,一季報(bào)后對(duì)業(yè)績(jī)的過(guò)高預(yù)期逐步修正,行業(yè)未來(lái)負(fù)面因素將逐步減少,預(yù)計(jì)二季度后期醫(yī)藥股將逐步迎來(lái)投資的機(jī)會(huì)。
| ||